Advanced search
Publication Cover
Cancer Management and Research Volume 10, 2018 - Issue
Submit an article Journal homepage
71
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality

Qian-Kun Xie1 VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
,
Wen-Zhuo He1 VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
,
Wan-Ming Hu2 Department of Pathology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, SunYat-sen University Cancer Center, Guangzhou, China;3 Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China;4 Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Lin Yang1 VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
,
Chang Jiang1 VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
,
Peng-Fei Kong1 VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
,
Yuan-Zhong Yang2 Department of Pathology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, SunYat-sen University Cancer Center, Guangzhou, China
,
Qiong Yang1 VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;5 Department of Oncology, Sun Yat-sen Memorial Hospital, Guangzhou, China
,
Hui-Zhong Zhang2 Department of Pathology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, SunYat-sen University Cancer Center, Guangzhou, China
,
Bei Zhang1 VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, ChinaCorrespondence[email protected]
&
Liang-Ping Xia1 VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, ChinaCorrespondence[email protected]
 show all
Pages 1365-1375 | Published online: 30 May 2018

References

  • MarkowitzSDBertagnolliMMMolecular origins of cancer: molecular basis of colorectal cancerN Engl J Med2009361252449246020018966
  • Van SchaeybroeckSAllenWLTurkingtonRCJohnstonPGImplementing prognostic and predictive biomarkers in CRC clinical trialsNat Rev Clin Oncol20118422223221321566
  • GeorgeBKopetzSPredictive and prognostic markers in colorectal cancerCurr Oncol Rep201113320621521373987
  • GalonJMlecnikBMarliotFValidation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: results of a worldwide consortium-based analysis of 1,336 patientsJ Clin Oncol20163415 suppl3500
  • RozekLSSchmitSLGreensonJKTumor-infiltrating lymphocytes, Crohn’s-like lymphoid reaction, and survival from colorectal cancerJ Natl Cancer Inst20161088
  • KhalilDNSmithELBrentjensRJWolchokJDThe future of cancer treatment: immunomodulation, CARs and combination immunotherapyNat Rev Clin Oncol201613527329026977780
  • SvennevigJLLundeOCHolterJBjørgsvikDLymphoid infiltration and prognosis in colorectal carcinomaBr J Cancer19844933753776704315
  • RopponenKMEskelinenMJLipponenPKAlhavaEKosmaVMPrognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancerJ Pathol199718233183249349235
  • GalonJCostesASanchez-CaboFType, density, and location of immune cells within human colorectal tumors predict clinical outcomeScience200631357951960196417008531
  • KlintrupKMakinenJMKauppilaSInflammation and prognosis in colorectal cancerEur J Cancer2005412645265416239109
  • QiuMHuJYangDCosgroveDPXuRPattern of distant metastases in colorectal cancer: a SEER based studyOncotarget20156386583866626484417
  • HugenNvan de VeldeCJde WiltJHNagtegaalIDMetastatic pattern in colorectal cancer is strongly influenced by histological subtypeAnn Oncol20142565165724504447
  • de VisserKEEichtenACoussensLMParadoxical roles of the immune system during cancer developmentNat Rev Cancer20066243716397525
  • BaldanVGriffithsRHawkinsREEfficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinomaBr J Cancer20151121510151825867267
  • KangBWSeoANYoonSPrognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancerAnn Oncol20162749450126673353
  • DenkertCLoiblSNoskeATumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancerJ Clin Oncol20102810511319917869
  • ZuckermanNSYuHSimonsDLAltered local and systemic immune profiles underlie lymph node metastasis in breast cancer patientsInt J Cancer20131322537254723136075
  • TaylorRCPatelAPanageasKSBusamKJBradyMSTumor- infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanomaJ Clin Oncol20072586987517327608
  • De HaasRJWichertsDAAndreaniPImpact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resectionAnn Surg20112531069107921451388
  • LoiSMichielsSSalgadoRTumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trialAnn Oncol2014251544155024608200
  • PruneriGLazzeroniMBagnardiVThe prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breastAnn Oncol20172832132828426105
  • UppalAFergusonMKPosnerMCHellmanSKhodarevNNWeichselbaumRRTowards a molecular basis of oligometastatic disease: potential role of micro-RNAsClin Exp Metastasis20143173574824968866
  • KitamuraTQianBZPollardJWImmune cell promotion of metastasisNat Rev Immunol201515738625614318
  • KimYWKimIYThe role of surgery for asymptomatic primary tumors in unresectable stage IV colorectal cancerAnn Coloproctol201329445423700570
  • ScheerMGSlootsCEvan der WiltGJRuersTJManagement of patients with asymptomatic colorectal cancer and synchronous irresectable metastasesAnn Oncol2008191829183518662955
  • HeWZRongYMJiangCPalliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigenChin J Cancer2016355827357402
  • TarantinoIWarschkowRWorniMPrognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: a population-based, propensity score-adjusted trend analysisAnn Surg201526211212025373464
  • SalgadoRDenkertCDemariaSThe evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Ann Oncol20152625927125214542

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.